Edition:
India

Genprex Inc (GNPX.OQ)

GNPX.OQ on NASDAQ Stock Exchange Capital Market

1.18USD
19 Jul 2019
Change (% chg)

$0.08 (+7.27%)
Prev Close
$1.10
Open
$1.12
Day's High
$1.20
Day's Low
$1.07
Volume
28,465
Avg. Vol
11,004
52-wk High
$7.88
52-wk Low
$0.95

About

Genprex, Inc. is a clinical stage gene therapy company. The Company is focused on developing cancer-based upon its novel proprietary technology platform, including its initial product candidate, Oncoprex, immunogene therapy, or Oncoprex. The Company’s Oncoprex is lead product candidate, is the subject of an ongoing Phase I/II... (more)

Overall

Beta: --
Market Cap(Mil.): $18.41
Shares Outstanding(Mil.): 15.60
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates